Registrant profile

Autobio Diagnostics Co., Ltd.

郑州安图生物工程股份有限公司
Henan·China NMPA·550 registered devices
550
Total devices
2
Device classes
2015
Earliest approval
2025
Latest approval
Company overview
Total devices
550
Province/Region
Henan
河南
Address
No. 87, Jingbei 1st Road, Zhengzhou Economic and Technological Development Zone
郑州经济技术开发区经北一路87号
Registration timeline
Earliest approval
May 19, 2015
Latest approval
Jan 20, 2025
Device class distribution
Breakdown of 550 devices by regulatory classification
Class II
383
69.6% of total
Class III
167
30.4% of total
Registered devices (10 most recent shown)
Click on any device for detailed registration information
Product nameClassRegistration numberApproval dateExpiry dateDetail
铜绿假单胞菌/流感嗜血杆菌/大肠埃希菌核酸检测试剂盒(PCR-荧光探针法)
Class III国械注准20253400200Jan 20, 2025Jan 19, 2030View
Thyroglobulin Antibody Calibration Kit
甲状腺球蛋白抗体校准品
Class II豫械注准20252400053Jan 15, 2025Jan 14, 2030View
甲状腺素校准品
Class II豫械注准20252400052Jan 14, 2025Jan 13, 2030View
三碘甲状腺原氨酸校准品
Class II豫械注准20252400051Jan 14, 2025Jan 13, 2030View
人表皮生长因子受体2校准品
Class III国械注准20253400059Jan 10, 2025Jan 09, 2030View
Cortisol calibration solution
皮质醇校准品
Class II豫械注准20252400025Jan 10, 2025Jan 09, 2030View
质谱分析校准品(N)
Class II豫械注准20252400027Jan 10, 2025Jan 09, 2030View
Thyroid Peroxidase Antibody Calibration Material
甲状腺过氧化物酶抗体校准品
Class II豫械注准20252400026Jan 10, 2025Jan 09, 2030View
Free Thyroxine Calibration Product
游离甲状腺素校准品
Class II豫械注准20252400023Jan 10, 2025Jan 09, 2030View
Osteocalcin calibration kit
骨钙素校准品
Class II豫械注准20252400024Jan 10, 2025Jan 09, 2030View
About this profile

Complete regulatory portfolio for Autobio Diagnostics Co., Ltd. in China's medical device market. This registrant has 550 medical devices registered with China NMPA, with registrations dating from May 19, 2015 to Jan 20, 2025.

Browse the complete device portfolio including device classifications, registration numbers, approval dates, and technical specifications. Pure Global AI provides free access to comprehensive China NMPA registration data, helping global MedTech companies analyze market presence and regulatory compliance for Chinese medical device manufacturers.